How effective is Myrbetriq for Urinary Incontinence? (by duration, gender, age)
Summary:
Overall ratings: 3.4/5 Long term ratings: 3.3/5
This is a phase IV clinical study of how effective Myrbetriq (mirabegron) is for Urinary incontinence and for what kind of people. The study is created by eHealthMe from 10 Myrbetriq users and is updated continuously.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
10 people are studied for taking Myrbetriq in Urinary incontinence
What is Myrbetriq?
Myrbetriq has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 28,494 Myrbetriq users for its effectiveness, alternative drugs and more.
What is Urinary incontinence?
Urinary incontinence (inability to control the flow of urine and involuntary urination) is found to be associated with 2,922 drugs and 2,313 conditions by eHealthMe.
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Myrbetriq effectiveness for Urinary incontinence (number of people):
Overall:
- not at all: 0
- somewhat: 2
- moderate: 3
- high: 4
- very high: 1
Long Term:
- not at all: 0
- somewhat: 1
- moderate: 2
- high: 3
- very high: 0
Gender of people who take Myrbetriq for Urinary incontinence *:
- female: 90 %
- male: 10 %
Age of people who take Myrbetriq for Urinary incontinence *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 20 %
- 50-59: 10 %
- 60+: 70 %
Who find Myrbetriq more effective for Urinary Incontinence?
Gender of people who take Myrbetriq for Urinary incontinence *:
- female: 100 %
- male: 0.0 %
Age of people who take Myrbetriq for Urinary incontinence *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 40 %
- 50-59: 0.0 %
- 60+: 60 %
* Approximation only. Some reports may have incomplete information.
Do you take Myrbetriq?
- You can start a phase IV clinical trial to monitor Myrbetriq safety and effectiveness.How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of:
- Myrbetriq (28,494 reports)
Treatments, associated drugs and conditions:
- Urinary incontinence (45,206 reports)
How the study uses the data?
The study is based on mirabegron (the active ingredients of Myrbetriq) and Myrbetriq (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Gastritis and Extranodal Marginal Zone B-Cell Lymphoma (Malt Type) - 4 seconds ago
- Lopurin and Iodixanol drug interaction - 5 seconds ago
- Cambia and Lymphoedema - 7 seconds ago
- Videx and Hyperventilation - 11 seconds ago
- Promethazine Hydrochloride and Back Pain - 13 seconds ago
- Veltassa and Zide drug interaction - 20 seconds ago
- Rythmol Sr and Loraz drug interaction - 20 seconds ago
- Brovana and Sucralfate drug interaction - 21 seconds ago
- Sovaldi and Frustration - 21 seconds ago
- Sinemet and Polycythemia Vera - 24 seconds ago